Shionogi & Co., Ltd. (4507.T)
JPY 2178.5
(0.51%)
JPY 2178.5
(0.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 171.46 Billion JPY | 15.07% |
| 2022 | 149 Billion JPY | 35.07% |
| 2021 | 110.31 Billion JPY | -6.07% |
| 2020 | 117.43 Billion JPY | -10.1% |
| 2019 | 130.62 Billion JPY | -5.71% |
| 2018 | 138.53 Billion JPY | 20.24% |
| 2017 | 115.21 Billion JPY | 6.51% |
| 2016 | 108.17 Billion JPY | 18.35% |
| 2015 | 91.4 Billion JPY | 81.49% |
| 2014 | 50.36 Billion JPY | -20.75% |
| 2013 | 63.55 Billion JPY | 8.0% |
| 2012 | 58.84 Billion JPY | 25.2% |
| 2011 | 47 Billion JPY | 0.24% |
| 2010 | 46.89 Billion JPY | -10.58% |
| 2009 | 52.43 Billion JPY | 63.8% |
| 2008 | 32.01 Billion JPY | -20.76% |
| 2007 | 40.39 Billion JPY | 39.97% |
| 2006 | 28.86 Billion JPY | -1.24% |
| 2005 | 29.22 Billion JPY | 1.73% |
| 2004 | 28.72 Billion JPY | 41.58% |
| 2003 | 20.29 Billion JPY | 5.33% |
| 2002 | 19.26 Billion JPY | 19.04% |
| 2001 | 16.18 Billion JPY | -32.31% |
| 2000 | 23.9 Billion JPY | -5.95% |
| 1999 | 25.42 Billion JPY | 10.96% |
| 1998 | 22.91 Billion JPY | 7.94% |
| 1997 | 21.22 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 48.53 Billion JPY | 72.65% |
| 2024 Q1 | 28.11 Billion JPY | 17.33% |
| 2023 Q1 | 46.58 Billion JPY | 1741.3% |
| 2023 Q3 | 40.63 Billion JPY | -21.14% |
| 2023 Q2 | 51.52 Billion JPY | 10.6% |
| 2023 FY | 171.46 Billion JPY | 15.07% |
| 2023 Q4 | 23.95 Billion JPY | -41.04% |
| 2022 Q2 | 15.8 Billion JPY | 27.22% |
| 2022 FY | 149 Billion JPY | 35.07% |
| 2022 Q4 | 2.53 Billion JPY | -97.86% |
| 2022 Q1 | 12.42 Billion JPY | -75.1% |
| 2022 Q3 | 118.24 Billion JPY | 648.32% |
| 2021 Q4 | 49.89 Billion JPY | 180.96% |
| 2021 Q3 | 17.75 Billion JPY | -25.61% |
| 2021 Q2 | 23.86 Billion JPY | 27.0% |
| 2021 FY | 110.31 Billion JPY | -6.07% |
| 2021 Q1 | 18.79 Billion JPY | 23.34% |
| 2020 FY | 117.43 Billion JPY | -10.1% |
| 2020 Q1 | 25.61 Billion JPY | -18.36% |
| 2020 Q2 | 29.69 Billion JPY | 15.9% |
| 2020 Q3 | 46.89 Billion JPY | 57.94% |
| 2020 Q4 | 15.23 Billion JPY | -67.51% |
| 2019 Q1 | 28.95 Billion JPY | -29.57% |
| 2019 Q2 | 31.52 Billion JPY | 8.86% |
| 2019 Q3 | 43.49 Billion JPY | 37.98% |
| 2019 FY | 130.62 Billion JPY | -5.71% |
| 2019 Q4 | 31.37 Billion JPY | -27.86% |
| 2018 Q2 | 29.65 Billion JPY | 7.28% |
| 2018 Q4 | 41.11 Billion JPY | 2.48% |
| 2018 FY | 138.53 Billion JPY | 20.24% |
| 2018 Q1 | 27.64 Billion JPY | 10.17% |
| 2018 Q3 | 40.11 Billion JPY | 35.27% |
| 2017 Q3 | 34.36 Billion JPY | -13.58% |
| 2017 Q2 | 39.76 Billion JPY | 148.74% |
| 2017 Q1 | 15.98 Billion JPY | -21.85% |
| 2017 FY | 115.21 Billion JPY | 6.51% |
| 2017 Q4 | 25.09 Billion JPY | -26.98% |
| 2016 FY | 108.17 Billion JPY | 18.35% |
| 2016 Q2 | 26.25 Billion JPY | 45.55% |
| 2016 Q1 | 18.03 Billion JPY | -30.5% |
| 2016 Q3 | 43.43 Billion JPY | 65.44% |
| 2016 Q4 | 20.45 Billion JPY | -52.89% |
| 2015 FY | 91.4 Billion JPY | 81.49% |
| 2015 Q3 | 31.52 Billion JPY | 47.3% |
| 2015 Q2 | 21.4 Billion JPY | 70.75% |
| 2015 Q1 | 12.53 Billion JPY | -12.35% |
| 2015 Q4 | 25.95 Billion JPY | -17.68% |
| 2014 Q3 | 13.34 Billion JPY | -9.02% |
| 2014 FY | 50.36 Billion JPY | -20.75% |
| 2014 Q2 | 14.67 Billion JPY | 82.26% |
| 2014 Q1 | 8.04 Billion JPY | -38.26% |
| 2014 Q4 | 14.29 Billion JPY | 7.13% |
| 2013 Q4 | 13.03 Billion JPY | -40.91% |
| 2013 FY | 63.55 Billion JPY | 8.0% |
| 2013 Q1 | 12.15 Billion JPY | -22.26% |
| 2013 Q2 | 16.3 Billion JPY | 34.07% |
| 2013 Q3 | 22.06 Billion JPY | 35.33% |
| 2012 Q4 | 15.64 Billion JPY | -8.55% |
| 2012 FY | 58.84 Billion JPY | 25.2% |
| 2012 Q2 | 13.89 Billion JPY | 13.81% |
| 2012 Q1 | 12.21 Billion JPY | -0.85% |
| 2012 Q3 | 17.1 Billion JPY | 23.07% |
| 2011 Q2 | 6.78 Billion JPY | -40.76% |
| 2011 Q4 | 12.31 Billion JPY | -25.13% |
| 2011 Q1 | 11.45 Billion JPY | 2.41% |
| 2011 Q3 | 16.44 Billion JPY | 142.43% |
| 2011 FY | 47 Billion JPY | 0.24% |
| 2010 Q2 | 11.25 Billion JPY | 41.27% |
| 2010 Q1 | 7.96 Billion JPY | -54.23% |
| 2010 Q4 | 11.18 Billion JPY | -32.14% |
| 2010 Q3 | 16.48 Billion JPY | 46.38% |
| 2010 FY | 46.89 Billion JPY | -10.58% |
| 2009 Q4 | 17.41 Billion JPY | 1.29% |
| 2009 Q2 | 11.75 Billion JPY | 93.47% |
| 2009 Q1 | 6.07 Billion JPY | -32.88% |
| 2009 FY | 52.43 Billion JPY | 63.8% |
| 2009 Q3 | 17.18 Billion JPY | 46.18% |
| 2008 Q3 | 4.49 Billion JPY | -56.7% |
| 2008 FY | 32.01 Billion JPY | -20.76% |
| 2008 Q4 | 9.05 Billion JPY | 101.45% |
| 2008 Q2 | 10.38 Billion JPY | 0.0% |
| 2007 FY | 40.39 Billion JPY | 39.97% |
| 2006 FY | 28.86 Billion JPY | -1.24% |
| 2005 FY | 29.22 Billion JPY | 1.73% |
| 2004 FY | 28.72 Billion JPY | 41.58% |
| 2003 FY | 20.29 Billion JPY | 5.33% |
| 2002 FY | 19.26 Billion JPY | 19.04% |
| 2001 FY | 16.18 Billion JPY | -32.31% |
| 2000 FY | 23.9 Billion JPY | -5.95% |
| 1999 FY | 25.42 Billion JPY | 10.96% |
| 1998 FY | 22.91 Billion JPY | 7.94% |
| 1997 FY | 21.22 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -3253.413% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 19.907% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 148.408% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 87798.39% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | -446.295% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -1702.376% |
| Eisai Co., Ltd. | 53.4 Billion JPY | -221.038% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -23846.927% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | -1202.195% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -2854.679% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -8630.143% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 34808.502% |
| Tsumura & Co. | 20.01 Billion JPY | -756.529% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -4168.359% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -3304.686% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | -871.555% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -4344.272% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | -1664.601% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -2751.488% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 5668.691% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -4303.184% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 21224.401% |
| MedRx Co., Ltd | -933 Million JPY | 18477.278% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -3228.036% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 15153.556% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 7334.599% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -2537.846% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | -807.868% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 24684.299% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | -786.969% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -3812.544% |